ISTH 2020 Congress
Platelet Disorders and von Willebrand Disease » Acquired Thrombocytopenias
Theme Navigation
- ISTH 2020 Congress
- Platelet Disorders and von Willebrand Disease
- Acquired Thrombocytopenias
- Platelet Disorders and von Willebrand Disease
-
Abstract Number: PB1365
A Long Term Survival Chronic DIC with ITP Treated with Low Dose Steroid
-
Abstract Number: PB1369
A Subpopulation of ITP Patients Resembling Glanzmann Thrombasthenia Phenotype Revealed by Flow Cytometry Analysis of Platelet Intracellular Signalling
-
Abstract Number: PB1335
Achieving Clinically Relevant Platelet Count Response Thresholds with Avatrombopag (AVA) in Immune Thrombocytopenia (ITP)
-
Abstract Number: PB1377
Antimicrobial Prophylaxis in Patients with Immune Thrombocytopenia Treated with Rituximab: A Retrospective Multicenter Analysis
-
Abstract Number: PB1327
Antithyroid Treatment Improves Thrombocytopenia in a Young Patient with Graves´ Disease: A Case Report
-
Abstract Number: PB1328
Apoptotic Markers May Help in Predicting the Disease Course of Pediatric Immune Thrombocytopenic Patients
-
Abstract Number: PB1366
Artificial Neural Network for Prediction of Hemorrhagic Severity in Patients with Immune Thrombocytopenia Purpura
-
Abstract Number: PB1331
Atorvastatin Restores the Imbalance of CD4+ T cells in Immune Thrombocytopenia via Ras/MEK/ERK and mTOR/PI3K/AKT Pathways
-
Abstract Number: PB1315
Can we Predict the Clinical Course of Children with ITP by MPV? A Preliminary Study
-
Abstract Number: PB1334
Can we Predict the Outcome of Splenectomy for Primary Immune Thrombocytopenia? Conclusion Based on Systematic Review and Meta-Analysis
-
Abstract Number: PB1346
CD4+ T Cell Expression of IL-10 Compared to IL-17 is Lower in Patients with Immune Thrombocytopenia (ITP) Who Do Not Respond Clinically to High Dose Corticosteroid
-
Abstract Number: PB1374
Characteristics and Outcome of Patients with Thrombocytopenia Secondary to Acute Cytomegalovirus Infection: Case Series and Literature Review
-
Abstract Number: PB1319
Characteristics of Patients with Cyclic Thrombocytopenia: An Observational Cohort Study
-
Abstract Number: PB1340
Clinical and Laboratory Factors Affecting Chronicity in Children Diagnosed with Immune Thrombocytopenia
-
Abstract Number: PB1347
Clinical Practise of SMOG System for Assessing Severity of Hemorrhagic Manifestations of Immume Thrombocytopenia (ITP) in Children
-
Abstract Number: PB1364
Comparison of Various Diagnostic Methods in Assessing Platelet Count in Patients with Immunotrombocytopenia
-
Abstract Number: PB1378
Corticosteroid Reduction or Discontinuation after Initiation of Avatrombopag Treatment in Patients with Chronic Immune Thrombocytopenia (ITP)
- 1
- 2
- 3
- 4
- Next Page »